Immunovant Stock Options
| IMVT Stock | USD 28.73 1.57 5.78% |
Immunovant's latest option contracts expiring on 2024-12-20 are carrying combined implied volatility of 0.13 with a put-to-call open interest ratio of 0.0 over 20 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-12-20. The total put volume is at 43.0, with calls trading at the volume of 43.0. This yields a 2.53 put-to-call volume ratio.
Immunovant's option chain provides insight into all available option contracts written on Immunovant's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Immunovant's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Immunovant option contract.
In The Money vs. Out of Money Option Contracts on Immunovant
Analyzing Immunovant's in-the-money options over time can help investors to take a profitable long position in Immunovant regardless of its overall volatility. This is especially true when Immunovant's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Immunovant's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Immunovant's stock while costing only a fraction of its price.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunovant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Immunovant In The Money Call Balance
When Immunovant's strike price is surpassing the current stock price, the option contract against Immunovant stock is said to be in the money. When it comes to buying Immunovant's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Immunovant are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Immunovant Current Options Market Mood
Immunovant's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Immunovant Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Immunovant's options investors are not very successful. Immunovant's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Immunovant contract
Base on the Rule 16, the options market is currently suggesting that Immunovant will have an average daily up or down price movement of about 0.008125% per day over the life of the 2024-12-20 option contract. With Immunovant trading at USD 28.73, that is roughly USD 0.002334. If you think that the market is fully incorporating Immunovant's daily price movement you should consider buying Immunovant options at the current volatility level of 0.13%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Immunovant |
Purchasing Immunovant options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Immunovant calls. Remember, the seller must deliver Immunovant stock to the call owner when a call is exercised.
Immunovant Option Chain
When Immunovant's strike price is surpassing the current stock price, the option contract against Immunovant stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Immunovant's option chain is a display of a range of information that helps investors for ways to trade options on Immunovant. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Immunovant. It also shows strike prices and maturity days for a Immunovant against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | IMVT Option Call 20-12-2024 24 | 0 | 2024-12-20 | 0.0 - 0.0 | 6.57 | In |
Call | IMVT Option Call 20-12-2024 25 | 0 | 2024-12-20 | 0.0 - 0.0 | 5.71 | In |
Call | IMVT Option Call 20-12-2024 26 | 0 | 2024-12-20 | 0.0 - 0.0 | 1.2 | In |
Call | IMVT Option Call 20-12-2024 27 | 0 | 2024-12-20 | 0.0 - 0.0 | 1.0 | In |
Call | IMVT Option Call 20-12-2024 28 | 0 | 2024-12-20 | 0.0 - 0.0 | 1.35 | In |
Call | IMVT Option Call 20-12-2024 29 | 0 | 2024-12-20 | 0.0 - 0.0 | 1.25 | |
Call | IMVT Option Call 20-12-2024 30 | 0 | 2024-12-20 | 0.0 - 0.0 | 1.0 | |
Call | IMVT Option Call 20-12-2024 31 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.33 | |
Call | IMVT Option Call 20-12-2024 32 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.65 | |
Call | IMVT Option Call 20-12-2024 33 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.16 | |
Call | IMVT Option Call 20-12-2024 35 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.14 | |
Call | IMVT Option Call 20-12-2024 37 | 9 | 2024-12-20 | 0.0 - 1.0 | 0.81 | Out |
Put | IMVT Option Put 20-12-2024 22 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.35 | |
Put | IMVT Option Put 20-12-2024 23 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.25 | |
Put | IMVT Option Put 20-12-2024 24 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.8 | |
Put | IMVT Option Put 20-12-2024 25 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.45 | |
Put | IMVT Option Put 20-12-2024 27 | 0 | 2024-12-20 | 0.0 - 0.0 | 1.58 | |
Put | IMVT Option Put 20-12-2024 28 | 0 | 2024-12-20 | 0.0 - 0.0 | 1.25 | |
Put | IMVT Option Put 20-12-2024 29 | 0 | 2024-12-20 | 0.0 - 0.0 | 1.5 | In |
Put | IMVT Option Put 20-12-2024 30 | 0 | 2024-12-20 | 0.0 - 0.0 | 1.45 | In |
Immunovant Total Stockholder Equity
Total Stockholder Equity |
|
Immunovant Corporate Management
| MD MBA | Executive Board | Profile | |
| Jay Stout | Chief Officer | Profile | |
| Mark JD | Chief Secretary | Profile | |
| Julia Butchko | Chief Officer | Profile | |
| Andy Deig | Senior Finance | Profile | |
| Mark Levine | Chief Secretary | Profile | |
| Lauren MBA | Vice Marketing | Profile |
Additional Tools for Immunovant Stock Analysis
When running Immunovant's price analysis, check to measure Immunovant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunovant is operating at the current time. Most of Immunovant's value examination focuses on studying past and present price action to predict the probability of Immunovant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunovant's price. Additionally, you may evaluate how the addition of Immunovant to your portfolios can decrease your overall portfolio volatility.